Literature DB >> 32523888

Physiologic Significance of Epigenetic Regulation of Thyroid Hormone Target Gene Expression.

João Anselmo1, Carolina M Chaves1.   

Abstract

BACKGROUND: In previous publications, we have reported our findings demonstrating that exposure to high maternal levels of thyroid hormones (TH) has life-long effects on the wild-type (WT, without THRB mutation) progeny of mothers with resistance to thyroid hormone beta (RTHβ). The mechanism of this epigenetic effect remains unclear.
OBJECTIVES: We reviewed the mechanisms involved in the epigenetic regulation of TH target genes and understand how they may explain the reduced sensitivity to TH in the WT progeny of RTHβ mothers.
METHODS: The availability of a large, formerly genotyped Azorean population with many individuals harboring the THRB mutation, R243Q, provided us a model to study the influence of fetal exposure to high maternal TH levels.
RESULTS: The thyroid-stimulating hormone (TSH) response in WT adults was less suppressible following the administration of L-triiodothyronine (L-T<sub>3</sub>). This finding suggests reduced sensitivity to TH that is induced by an epigenetic mechanism resulting from exposure to high maternal levels of TH during pregnancy. The persistence of this effect across 3 generations of WT subjects favors transgenerational epigenetic inheritance. Based on preliminary studies in mice, we identified the naturally imprinted gene encoding deiodinase type 3, i.e., DIO3, as a possible mediator of this epigenetic effect through increased inactivation of TH.
CONCLUSION: Increased D3 expression and consequently increased T<sub>3</sub> degradation appear to be responsible for the reduced sensitivity of the anterior pituitary to administered L-T<sub>3</sub>. The imprinted DIO3 gene may be a candidate gene that mediates the epigenetic effect induced by exposure to high maternal levels of TH. However, we cannot exclude the role of other TH-responsive genes.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Deiodinase type 3; Epigenetic regulation; Resistance to thyroid hormone beta; Transgenerational inheritance

Year:  2020        PMID: 32523888      PMCID: PMC7265707          DOI: 10.1159/000506423

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  29 in total

Review 1.  Membrane receptors mediating thyroid hormone action.

Authors:  Paul J Davis; Faith B Davis; Vivian Cody
Journal:  Trends Endocrinol Metab       Date:  2005-10-07       Impact factor: 12.015

2.  Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene.

Authors:  S J Usala; A E Bale; N Gesundheit; C Weinberger; R W Lash; F E Wondisford; O W McBride; B D Weintraub
Journal:  Mol Endocrinol       Date:  1988-12

3.  Thyroid Hormone Signaling Pathways: Time for a More Precise Nomenclature.

Authors:  Frédéric Flamant; Sheue-Yann Cheng; Anthony N Hollenberg; Lars C Moeller; Jacques Samarut; Fredric E Wondisford; Paul M Yen; Samuel Refetoff
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

4.  Genomic imprinting of DIO3, a candidate gene for the syndrome associated with human uniparental disomy of chromosome 14.

Authors:  Maria Elena Martinez; David F Cox; Brian P Youth; Arturo Hernandez
Journal:  Eur J Hum Genet       Date:  2016-06-22       Impact factor: 4.246

5.  Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity.

Authors:  H Yagi; J Pohlenz; Y Hayashi; A Sakurai; S Refetoff
Journal:  J Clin Endocrinol Metab       Date:  1997-05       Impact factor: 5.958

6.  Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.

Authors:  Kathleen C Lee; Jiwen Li; Philip A Cole; Jiemin Wong; W Lee Kraus
Journal:  Mol Endocrinol       Date:  2003-02-13

Review 7.  The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance.

Authors:  Orsolya Dohán; Antonio De la Vieja; Viktoriya Paroder; Claudia Riedel; Mona Artani; Mia Reed; Christopher S Ginter; Nancy Carrasco
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

8.  Type 3 deiodinase deficiency results in functional abnormalities at multiple levels of the thyroid axis.

Authors:  Arturo Hernandez; M Elena Martinez; Xiao-Hui Liao; Jacqueline Van Sande; Samuel Refetoff; Valerie Anne Galton; Donald L St Germain
Journal:  Endocrinology       Date:  2007-09-06       Impact factor: 4.736

9.  Fetal loss associated with excess thyroid hormone exposure.

Authors:  João Anselmo; Dingcai Cao; Theodore Karrison; Roy E Weiss; Samuel Refetoff
Journal:  JAMA       Date:  2004-08-11       Impact factor: 56.272

10.  Global Transcriptome Analysis of Primary Cerebrocortical Cells: Identification of Genes Regulated by Triiodothyronine in Specific Cell Types.

Authors:  Pilar Gil-Ibañez; Francisco García-García; Joaquín Dopazo; Juan Bernal; Beatriz Morte
Journal:  Cereb Cortex       Date:  2017-01-01       Impact factor: 5.357

View more
  3 in total

Review 1.  Thyroid hormone signaling in the intestinal stem cells and their niche.

Authors:  Maria Virginia Giolito; Michelina Plateroti
Journal:  Cell Mol Life Sci       Date:  2022-08-10       Impact factor: 9.207

2.  Thyroid Function at Age Fifty After Prenatal Famine Exposure in the Dutch Famine Birth Cohort.

Authors:  Sarai M Keestra; Irina Motoc; Anita C J Ravelli; Tessa J Roseboom; Martijn J J Finken
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-30       Impact factor: 6.055

Review 3.  Neuropsychological Alterations in Patients with Congenital Hypothyroidism Treated with Levothyroxine: Linked Factors and Thyroid Hormone Hyposensitivity.

Authors:  Karla Cristina Razón-Hernández; Norma Osnaya-Brizuela; Armando Valenzuela-Peraza; Esperanza Ontiveros-Mendoza; Luis Miguel Rodríguez-Serrano; Jorge Pacheco-Rosado; Gerardo Barragán-Mejía; Karla Sánchez-Huerta
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.